Alpha 2.0
Login Register
» Authors » Adrianna Mroz

Adrianna Mroz

Explore the profile of Adrianna Mroz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 6
Followers 0
Related Specialties
Oncology
Nuclear Medicine
Endocrinology
Top 10 Co-Authors
Grzegorz Kaminski
Beata Dmochowska
Marek Saracyn
Adam Daniel Durma
Katarzyna Jozwik-Plebanek
Maciej Kolodziej
Wawrzyniec Zmudzki
Beata Kos-Kudla
Dorota Brodowska-Kania
Waldemar Kapusta
Published In
Nucl Med Rev Cent East Eur
Cancers (Basel)
J Ultrason
Pharmaceuticals (Basel)
Endokrynol Pol
Affiliations
Soon will be listed here.
Recent Articles
1.
Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study
Durma A, Saracyn M, Kolodziej M, Jozwik-Plebanek K, Brodowska-Kania D, Dmochowska B, et al.
Cancers (Basel) . 2024 Oct; 16(20). PMID: 39456603
Background: Neuroendocrine neoplasms (NENs) are neoplastic tumors developing in every part of the body, mainly in the gastrointestinal tract and pancreas. Their treatment involves the surgical removal of the tumor...
2.
The challenging differential diagnosis of recurrent flushing episodes: systemic mastocytosis mimicking carcinoid syndrome
Brodowska-Kania D, Saracyn M, Mroz A, Osial N, Dmochowska B, Zmudzki W, et al.
Endokrynol Pol . 2024 Sep; 75(4):452-453. PMID: 39279316
Not required for Clinical Vignette.
3.
A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE
Klosinska M, Kolodziej J, Mroz A, Madra W, Kaminski G
Nucl Med Rev Cent East Eur . 2024 Sep; 27(0):39-41. PMID: 39229720
Glucagonoma is a rare pancreatic neuroendocrine tumor (panNET) that can be characterized by increased secretion of glucagon and distinguishing symptoms - glucagonoma syndrome with a typical dermatosis, necrolytic migratory erythema,...
4.
Re-treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE of patients with progressive neuroendocrine neoplasm
Durma A, Saracyn M, Kolodziej M, Jozwik-Plebanek K, Mroz A, Kapusta W, et al.
Nucl Med Rev Cent East Eur . 2024 Jul; 26(0):143-152. PMID: 38966954
Background: Neuroendocrine neoplasms (NENs) are heterogeneous groups of tumours derived from neuroendocrine cells of the ectoderm or endoderm. They are considered rare, with an estimated incidence and prevalence of 6/100,000...
5.
Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [Lu]Lu-DOTA-TATE or [Lu]Lu-DOTA-TATE and [Y]Y-DOTA-TATE-A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center
Durma A, Saracyn M, Kolodziej M, Jozwik-Plebanek K, Dmochowska B, Kapusta W, et al.
Cancers (Basel) . 2023 Nov; 15(22). PMID: 38001726
Neuroendocrine neoplasms (NENs) are a group of neoplasms arising from neuroendocrine cells. The worldwide incidence and prevalence of the NENs are estimated to be 6/100,000 and 35/100,000, respectively. Those numbers...
6.
Radioligand Therapy with [Lu]Lu-DOTA-TATE or [Lu]Lu-DOTA-TATE and [Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade
Durma A, Saracyn M, Kolodziej M, Jozwik-Plebanek K, Dmochowska B, Mroz A, et al.
Pharmaceuticals (Basel) . 2023 Sep; 16(9). PMID: 37765013
Background: Neuroendocrine neoplasms (NENs) are a rare group of tumors with a different clinical course, prognosis and location. Radioligand therapy (RLT) can be used as a first or second line...
7.
Duplicated inferior vena cava with coexisting multiple vascular anomalies and their clinical implications: a case report
Golabek C, Druc K, Dusinska Z, Franke J, Glowacki E, Kuskowska A, et al.
J Ultrason . 2019 Dec; 19(78):236-239. PMID: 31807330
The paper presents the case of a 23-year-old man with multiple venous anomalies. The abnormalities were asymptomatic, and they were detected accidentally on routine abdominal ultrasound examination. The anomalies were...